Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HR+/HER2-breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04448886
What this trial is testing

Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC

Who this might be right for
Invasive Breast CancerMetastatic Breast CancerHR-Positive Breast Cancer+1 more
Ana C Garrido-Castro, MD 110
Large-scale testing (Phase 3)Looking for participantsNCT07237256
What this trial is testing

Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Adjuvant Ribociclib

Who this might be right for
Breast Cancer
UNICANCER 3,902
Early research (Phase 1)UnknownNCT05337657
What this trial is testing

A Phase Ib Study of GB491 Plus Letrozole in Patients With Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
Genor Biopharma Co., Ltd. 10
Large-scale testing (Phase 3)Looking for participantsNCT06913777
What this trial is testing

Neoadjuvant SNF Precision Therapy Phase III

Who this might be right for
Neoadjuvant Therapy
Fudan University 404
Early research (Phase 1)Looking for participantsNCT06678269
What this trial is testing

Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast CancerStage IV Breast CancerBreast Cancer+5 more
Memorial Sloan Kettering Cancer Center 28
Testing effectiveness (Phase 2)UnknownNCT06000033
What this trial is testing

Study of Disitamab Vedotin and Anlotinib in Patients With HR-Negative, HER2-Low-Expressing Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Qilu Hospital of Shandong University 35
Testing effectiveness (Phase 2)Ended earlyNCT03101748
What this trial is testing

Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer

Who this might be right for
Breast Inflammatory CarcinomaLocally Advanced Breast CarcinomaMetastatic Breast Carcinoma+5 more
M.D. Anderson Cancer Center 34
Testing effectiveness (Phase 2)Looking for participantsNCT07109726
What this trial is testing

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Who this might be right for
Breast CancerEndometrial CancerOvarian Cancer+5 more
Terremoto Biosciences Inc. 205
Not applicableStudy completedNCT07561346
What this trial is testing

Clinico-pathological and Genomic Features of HER2-low Early Breast Cancer

Who this might be right for
HER2-zero, HER2-low and HER2-positive Tumors Distribution Across HR Expression Categories
Hellenic Cooperative Oncology Group 3,648
Early research (Phase 1)Active Not RecruitingNCT06299124
What this trial is testing

A Phase I Study of RGT-419B in Patients With HR-Positive, HER2-Negative Advanced Breast Cancer or Other Solid Tumors

Who this might be right for
Breast CancerAdvanced Solid Tumor
Regor Pharmaceuticals Inc. 40
Testing effectiveness (Phase 2)Looking for participantsNCT06276868
What this trial is testing

Darsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HR+/HER2+ Breast Cancer

Who this might be right for
Breast CancerHER2-positive Breast Cancer
Henan Cancer Hospital 71
Large-scale testing (Phase 3)Active Not RecruitingNCT05346224
What this trial is testing

Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast Cancer

Who this might be right for
Breast CancerBreast NeoplasmsHER2-positive Breast Cancer
Shanghai Henlius Biotech 900
Testing effectiveness (Phase 2)Study completedNCT04796623
What this trial is testing

TQB3616 Capsules Combined With Fulvestrant Injection in Subjects With Advanced Breast Cancer

Who this might be right for
HR-positive, HER2-negative Advanced Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 122
Large-scale testing (Phase 3)Active Not RecruitingNCT06112379
What this trial is testing

A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer

Who this might be right for
Breast Cancer
AstraZeneca 1,902
Testing effectiveness (Phase 2)Looking for participantsNCT06705127
What this trial is testing

Radiotherapy Followed by Chemotherapy Combined With Toripalimab in Local Advanced HR-positive,HER2-negative BC.

Who this might be right for
HR-positive,HER2-negative Breast Cancer
First Affiliated Hospital of Zhejiang University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06950086
What this trial is testing

Study of TYK-00540 Tablets in Patients With Advanced Solid Tumors

Who this might be right for
HR-positive, HER2-negative Advanced Breast Cancer
TYK Medicines, Inc 180
Testing effectiveness (Phase 2)Study completedNCT03555877
What this trial is testing

Anti-hormonal Therapie With Ribociclib in HR-positive / HER2- Negative Metastatic Breast Cancer

Who this might be right for
Breast Cancer Metastatic
GBG Forschungs GmbH 56
Large-scale testing (Phase 3)Ended earlyNCT01773460
What this trial is testing

Everolimus Beyond Progress for Patients Who Had Progress Under Everolimus and Exemestane

Who this might be right for
Metastatic Breast Cancer
GBG Forschungs GmbH 3
Testing effectiveness (Phase 2)Study completedNCT03839823
What this trial is testing

Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 222
Testing effectiveness (Phase 2)Looking for participantsNCT07661927
What this trial is testing

Skipping Hormone Therapy in Low-Risk Early Breast Cancer

Who this might be right for
Breast Cancer (Early Breast Cancer)
UNICANCER 700
Next Page